Amneal Scores Second US Biosimilar Approval With Avastin Rival

Alymsys Bevacizumab With mAbxience Is Second Of Three Expected Nods This Year

 
• By David Wallace
  
1 2 3 pool billiard balls
Amneal now has two biosimilar approvals and is lining up a third • Source: amana images inc. / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products